How should minimally important change scores for the Patient‐Oriented Eczema Measure be interpreted? A validation using varied methods

Por Howells, L., Ratib, S., Chalmers, J.R., Bradshaw, L., Thomas, K.S.
Publicado no Br J Dermatol (2018)

Doxycycline compared to prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial

Por Mason, JM, Chalmers, JR, Godec, T, Nunn, AJ, Kirtschig, G, Wojnarowska, F, Childs, M, Whitham, D, Schmidt, E, Harman, K, Walton, S, Chapman, A, Williams, HC
Publicado no Br J Dermatol (2018)

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)

Por Chalmers, JR, Schmitt, J, Apfelbacher, C, Dohil, M, Eichenfield, LF, Simpson, EL, Singh, J, Spuls, P, Thomas, KS, Admani, S, Aoki, V, Ardeleanu, M, Barbarot, S, Berger, T, Bergman, JN, Block, J, Borok, N, Burton, T, Chamlin, SL, Deckert, S, DeKlotz, CC, Graff, LB, Hanifin, JM, Hebert, AA, Humphreys, R, Katoh, N, Kisa, RM, Margolis, DJ, Merhand, S, Minnillo, R, Mizutani, H, Nankervis, H, Ohya, Y, Rodgers, P, Schram, ME, Stalder, JF, Svensson, A, Takaoka, R, Teper, A, Tom, WL, von Kobyletzki, L, Weisshaar, E, Zelt, S, Williams, HC
Publicado no Br J Dermatol (2014)